Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 1 Safety-interaction Study of Mirtazapine for the Treatment of Methamphetamine Use Disorder

NCT04614584 is registered in ClinicalTrials.gov with San Francisco Department of Public Health as lead sponsor.

NCT NCT04614584
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04614584 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 1 Safety-interaction Study of Mirtazapine for the Treatment of Methamphetamine Use Disorder
Lead sponsor
San Francisco Department of Public Health
Phase
Phase 1
Overall status
Completed
Start date
May 3, 2021
Completion date
May 31, 2024
Enrollment
15 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

cardiovascular abnormalities, drug interaction, methamphetamine use disorder